A Phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer.
Year: 2003
Type: article
Study design: Clinical Trial
Source: PubMed
Authors: Andrew M Scott, Greg Wiseman, Sydney Welt, Alex Adjei, Fook-Thean Lee, Wendie Hopkins, Chaitan R Divgi, Lorelei H Hanson, Paul Mitchell, Denise N Gansen, Steven M Larson, James N Ingle, Eric W Hoffman, Paul Tanswell, Gerd Ritter, Leonard S Cohen, Peter Bette, Lisa Arvay, Andree Amelsberg, Dan Vlock, Wolfgang J Rettig, Lloyd J Old
Institution: Ludwig Cancer Research
Language: English
Subfield: Biochemistry
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2102251969